ANEMIA AND RHEUMATOID ARTHRITIS
Анотація
The represented analysis of literature is dedicated to the problem of anemia development at rheumatoid arthritis (RA), which develops in 36-65% of cases. It is accompanied hypoxia of tissues and can, on the one hand lead to damage of various organs and systems, and with another – to deterioration of a clinical course and the prognosis of the patient. Pathogenetic mechanisms of an anaemia in RА: change of a metabolism of iron, life shortening of erythrocyte, or their inadequate production a bone marrow, a role of proinflammatory cytokines, drugs and genetic factors. We investigated the role of those medicines, which is used in the treatment of this pathology and improved quality of life.
Завантаження
##plugins.generic.usageStats.noStats##
Посилання
1. Коваленко В.М. Хвороби системи кровообігу: динаміка та аналіз / В.М. Коваленко, В.М Корнаць-кий // Аналітично-статистичний посібник. – 2008. – С. 66–79.
2. Wolfe F. Anemia and renal function in patients with rheumatoid arthritis / F. Wolfe, K. Michaud // J. Rheumatol. – 2006. – № 8. – Р.1467–1468.
3. Peeters H.R. Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset / H.R . Peeters, М. Jongen-Lavrencic // Ann Rheum Dis. – 1996. – № 55. – Р.162–168.
4. Doyle M.K. Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality / М.К. Doyle, M.U. Rahman, C. Han // J. Rheumatol. – 2008. – № 3. – Р.380–386.
5. Nikolaisen C. The differentiation of anaemia in rheumatoid arthritis: parameters of iron-deficiency in an Indian rheumatoid arthritis population / С. Nikolaisen, Y. Figenschau, J.C. Nossent // Rheumatol Int. – 2008. – № 6. – Р.507–511.
6. Ravindran V. Anemia in rheumatoid arthritis: high prevalence of iron-deficiency anemia in Indian pa-tients / V. Ravindran, S. Jain, D.S. Mathur // Rheumatol Int. – 2006. – № 12. – Р.1091–1095.
7. Agrawal S. Anaemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness / S. Agrawal, R. Misra, A. Aggrawal // Ann Rheum Dis. – 1990. – № 2. – Р. 93–98.
8. Vreugdenhil G. Anaemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness / G. Vreugdenhil, A.W. Wognum, H.G. van Eijk, A.J. Swaak // Ann Rheum Dis. – 1990. – № 2. – Р. 93–98.
9. Kuruvilla J. Aplastic anemia following administration of a tumor necrosis factor-alpha inhibitor / J. Ku-ruvilla, H.A. Leitch, L.M. Vickars // Eur J Haematol. – 2003. – № 5. – Р. 396–398.
10. Vucelić V. Combined megaloblastic and immunohemolytic anemia associated--a case report / V. Vucelić, V. Stancić, M. Ledinsky // Acta Clin Croat. – 2008. – № 4. – Р.239–243.
11. Соломатина М.А. Анемия при хронических заболеваниях / М.А. Соломатина, В.К. Альпидовский // Вестник Российского университета дружбы народов. – 1999. – № 1. – С. 36–38.
12. Raj D.S. Role of Interleukin-6 in the Anemia of Chronic Disease / D.S Raj // Semin Arthritis Rheum. – 2009. – № 5. – Р. 382–388.
13. Matsumura I. Pathogenesis of anemia of chronic disease / I. Matsumura, Y. Kanakura // Nippon Rinsho. – 2008. – № 3. – Р. 535–539.
14. Weiss G. Pathogenesis and treatment of anaemia of chronic disease / G. Weiss // Blood Rev. – 2002. – № 2. – Р. 87–96.
15. Maciejewski J.Р. Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha // J.Р Maciejewski, С. Selleri, T. Sato // J. Clin Invest. – 1995. – №96. – Р. 1085–1092.
16. Rafferty S.P. Inhibition of hemoglobin expression by heterologous production of nitric oxide synthase in the K562 erythroleukemic cell line / S.P. Rafferty, J.B. Domachowske, H.L. Malech // Blood. – 1996. – № 88. – Р. 1070–1078.
17. Li H. Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS / Н. Li, M.J. Rose, L. Tran, J. Zhang, L.P. Miranda, С.А. James, B.J. Sasu // J. Pharmacol Toxicol Methods. – 2009. – № 179. – Р. 171–180.
18. Raj D.S. Role of Interleukin-6 in the Anemia of Chronic Disease / D.S Raj // Semin Arthritis Rheum. – 2009. – № 5. – Р. 382–388.
19. Pigeon C. A new mouse liver specific protein homologous to human antibacterial peptid hepcidin is overexpressed during iron overload / С. Pigeon, G. Ilyin, В. Courselaud // J. Biol. Chem. – 2001. – № 276. – Р. 7811–7819.
20. Kemna E. Time_course analisis of hepcidin, serum iron and plasma cytokine levels in humans injected with LPS / Е. Kemna, Р. Pickkers, Е. Nemeth // Blood. – 2005. – № 5. – Р. 1864–1866.
21. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin / M.D. Knutson, М. Oukka, L.M. Koss [et al.] // Proc Natl Acad Sci U S A. – 2005. – № 102. – Р. 1324-1328.
22. Evidence for differential effects of hepcidin in macrophages and intestinal epithelial cells. Gut. 2008 Mar; 57(3):374-82. Chaston T. Evidence for differential effects of hepcidin in macrophages and in-testinal epithelial cells / Т. Chaston, В. Chung, М. Mascarenhas [et al.] // Gut. – 2008. – № 57. – Р. 374–382.
23. Lang F. Mechanisms and significance of eryptosis / F. Lang, K.S. Lang, Р.А. Lang // Antioxid Redox Signal. – 2006. – № 8. – Р. 1183–1192.
24. Moldawer L.L. Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo / L.L. Moldawer, М.А. Marano, Н. Wei // FASEB J. – 1989. – № 3. – Р. 1637–1643.
25. Weiss G. Anemia of Chronic Disease / G. Weiss, L.T Goodnough // New. Eng. J. Med. – 2005. – № 10. – Р. 1011–1023.
26. Вуд Мари Э. Секреты гематологии и онкологии / Мари Э.Вуд, Пол А.Банн [пер. с англ.].- Москва : Бином, 1997. –38 c.
27. Baer A.N. The pathogenesis of anemia in rheumatoid arthritis: a clinical and laboratory analysis / A.N. Baer, E.N. Dessypris, S.B. Krantz // Semin Arthritis Rheum. – 1990. – № 4. – Р. 209–223.
28. Smith M.A. Anaemia of chronic disease in rheumatoid arthritis: effect of the blunted response to erythro-poietin and of interleukin 1 production by marrow macrophages // М.А. Smith, S.M. Knight, P.J. Maddi-son // Ann Rheum Dis. – 1992. – № 6. – Р. 753–757.
29. Kullich W. Effects of the chemokine MIP-1alpha on anemia and inflammation in rheumatoid arthritis / W. Kullich, F. Niksic, K. Burmucic // Z Rheumatol. – 2002. – № 61. – Р. 568–576.
30. Zhu Y. The correlation of cytokines TNF alpha, IFN-gamma, Epo with anemia in rheumatoid arthritis / Y. Zhu, D. Ye, Z. Huang // Zhonghua Xue Ye Xue Za Zhi. – 2000. – № 21. – Р. 587–590.
31. Means R.T. Recent developments in the anemia of chronic disease / R.T. Means // Curr. Hematol. Rep. – 2003. – № 2. – Р. 116–121.
32. Papadaki H.A. Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy / Н.А. Papadaki, H.D. Kritikos, V. Valatas // Blood. – 2002. – № 100. – Р. 474–482.
33. Glossop J.R. Anemia in rheumatoid arthritis: association with polymorphism in the tumor necrosis factor receptor I and II genes / J.R. Glossop, P.T. Dawes, A.B. Hassell // J Rheumatol. – 2005. – № 9. – Р. 1673–1678.
34. Segal R., Baumoehl Y., Elkayam O. (2004) Anemia, serum vitamin B12, and folic acid in patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus. Rheumatol Int, 24(1): 14–19.
35. Nakazaki S. Cytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis / S. Nakazaki, Т. Murayama // Ryumachi. – 2001. – № 6. – Р. 929–937.
36. Bolla G. Concurrent acute megaloblastic anaemia and pneumonitis: a severe side-effect of low-dose methotrexate therapy during rheumatoid arthritis / G. Bolla, Р. Disdier, J.R. Harle // Clin Rheumatol. – 1993. – № 4. – Р. 535–537.
37. Lim A.Y. Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years / A.Y. Lim, K.Gaffney, D.G. Scott // Rheumatology – 1995. – № 8. – Р. 1051–1055.
38. Hirshberg B. Safety of low dose methotrexate in elderly patients with rheumatoid arthritis / В. Hirshberg, M.Muszkat, O.Schlesinger // Postgrad Med J. – 2000. – № 902. – Р. 787–789.
39. Nurmohamed М.Т. Cyclosporin for sulphasalazine-induced aplastic anaemia in a patient with early rheumatoid arthritis / М.Т. Nurmohamed, М.Soesan, М.Н. van Oers // Rheumatology. – 2000. – № 12. – Р. 1431–1433.
40. Yan A. Gold induced marrow suppression: a review of 10 cases / А. Yan, P. Davis // J Rheumatol. – 1990. – № 1. – Р. 47–51.
41. Azathioprine-induced suicidal erythrocyte death / С. Geiger, M. Föller, K.R. Herrlinger [et al.] // Inflamm Bowel Dis. – 2008. – № 8. – Р. – 1027–1032.
42. Effects of chloroquine treatment on circulating erythropoietin and inflammatory cytokines in acute Plas-modium falciparum malaria / А. Ballal, A. Saeed, P. Rouina [et al.] // Ann Hematol. – 2009. – № 5. – Р. 411–415.
43. Giordano N. Increased storage of iron and anaemia in rheumatoid arthritis: usefulness of desferriox-amine / N. Giordano, A. Fioravanti, S. Sancasciani // Br Med J. – 1984. – № 6450. – Р. 961–962.
44. Red cell ferritin content: a re-evaluation of indices for iron deficiency in the anaemia of rheumatoid ar-thritis / А. Davidson, М.В. Van der Weyden [et al.] // Br Med J. – 1984. – № 289. – Р. 648–650.
45. Saravana S. Anemia of chronic disease in patients with rheumatoid arthritis--use of zinc protoporphyrin (ZPP) levels / S. Saravana, A. Rai // J Rheumatol. 1990. – № 2. – Р. 446.
46. Garrett S. Zinc protoporphyrin and iron-deficient erythropoiesis / S. Garrett, M. Worwood // Acta Hae-matol. – 2004. – № 91. – Р. 21–25.
47. Hastka J. Zinc protoporphyrin in anemia of chronic disorders / J. Hastka, J.J.Lasserre, A. Schwarzbeck // Blood. – 1993. – № 81. – Р. 1200–1204.
48. Margetic S. Soluble transferrin receptor and transferrin receptor-ferritin index in iron deficiency anemia and anemia in rheumatoid arthritis / S. Margetic, E. Topic, D.F Ruzic // Clin Chem Lab Med. – 2005. – № 3. – Р. 326–331.
49. Chijiwa Т. Serum transferrin receptor levels in patients with rheumatoid arthritis are correlated with indi-cators for anaemia / Т. Chijiwa, К.Nishiya, К.Hashimoto // Clin Rheumatol. – 2001. – № 5. – Р. 307–313.
50. Doyle M.К. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials / М.К. Doyle, M.U. Rahman, C. Han // Semin Arthritis Rheum. – 2009. – № 2. – Р.123–131. Epub 2008.
51. Dufour C. Etanercept as a salvage treatment for refractory aplastic anemia / С. Dufour, R. Giacchino, P. Ghezzi // Pediatr Blood Cancer. – 2009. – № 4. – Р. 522–525.
52. Ortiz Z. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheu-matoid arthritis / Z. Ortiz, В. Shea, М. Suarez Almazor // Cochrane Database Syst Rev. – 2008. – № 2.
53. Harten Р. Reducing toxicity of methotrexate with folic acid / Р. Harten // Z Rheumatol. – 2005. – № 5. – Р. 353–358.
54. Morgan S.L. Methotrexate in rheumatoid arthritis: folate supplementation should always be given / S.L. Morgan, J.E. Baggott, G.S. Alarcón // BioDrugs. – 1997. – № 3. – Р. 164–175.
55. NKF-K/DOQI Clinical Practice Guidelines for anemia of chronic kidney disease: update 2000 // Am. J. Kidney Dis. — 2001. – № 37. – Р. 182–238.
56. Ruiz-Argüelles G.J. Ineffectiveness of oral iron hydroxide polymaltose in iron-deficiency anemia / G.J. Ruiz-Argüelles, А. Díaz-Hernández, С. Manzano // Hematology. – 2007. – № 12. – Р. 255–256.
57. Reynoso-Gómez Е. Safety and efficacy of total dose intravenous iron infusion in the treatment of iron-deficiency anemia in adult non-pregnant patients / Е. Reynoso-Gómez, V. Salinas-Rojas, А. Lazo- Langner // Rev Invest Clin. – 2002. – № 54. – Р. 12–20.
58. Weiss G., Goodnough L.T. Anemia of Chronic Disease / G. Weiss, L.T. Goodnough // New. Eng. J. Med. -2005. – № 10. – Р. 1011–1023.
59. Vidal-Alaball J. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency / J. Vi-dal-Alaball, С.С. Butler, К. Hood // Cochrane Database Syst Rev. – 2005. – № 3.
60. Bolaman Z. Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study / Z. Bolaman, G. Kadikoylu, V. Yukselen // Clin Ther. – 2003. – № 12. – Р. 3124–3134.
61. Dyjas R. Influence of recombinant human erythropoietin (rHuEPO) on plasma levels of selected hor-mones in females with rheumatoid arthritis / R. Dyjas, M. Bułanowski, R. Ficek // Pol Arch Med Wewn. – 2005. – № 114. – Р. 731–737.
62. Arndt U. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin / U. Arndt, J.P. Kaltwasser, R. Gottschalk // Ann Hematol. – 2005. – № 3. – Р. 159–166.
63. Pettersson Т. Effect of exogenous erythropoietin on haem synthesis in anaemic patients with rheumatoid arthritis / Т. Pettersson, К. Rosenlöf, Е. Laitinen // Br J Rheumatol. – 2004. – № 6. – Р. 526–529.
64. Gudbjörnsson B. Response of anaemia in rheumatoid arthritis to treatment with subcutaneous recombi-nant human erythropoietin / В. Gudbjörnsson, R. Hällgren, L. Wide // Ann Rheum Dis. – 1992. – № 6. – Р. 747–752.
65. Peeters H.R. Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset / H.R. Peeters, M. Jongen-Lavrencic // Ann Rheum Dis. – 1996. – № 55. – Р. 162–168
66. Bhattacharya N. Placental umbilical cord whole blood transfusion to combat anemia in the background of advanced rheumatoid arthritis and emaciation and its potential role as immunoadjuvant therapy / N. Bhattacharya // Clin Exp Obstet Gynecol. – 2006. – № 33. – Р. 28–33.
67. Burt R.K. Future strategies in hematopoietic stem cell transplantation for rheumatoid arthritis / R.K. Burt, W. Barr, Y. Oyama // J Rheumatol Suppl. – 2001. – № 64. – Р. 42–48.
68. Lowenthal R.M. Twenty-year remission of rheumatoid arthritis in 2 patients after allogeneic bone mar-row transplant / R.M. Lowenthal, D.S. Gill // J Rheumatol. – 2006. – № 33. – Р. 812–813.
2. Wolfe F. Anemia and renal function in patients with rheumatoid arthritis / F. Wolfe, K. Michaud // J. Rheumatol. – 2006. – № 8. – Р.1467–1468.
3. Peeters H.R. Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset / H.R . Peeters, М. Jongen-Lavrencic // Ann Rheum Dis. – 1996. – № 55. – Р.162–168.
4. Doyle M.K. Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality / М.К. Doyle, M.U. Rahman, C. Han // J. Rheumatol. – 2008. – № 3. – Р.380–386.
5. Nikolaisen C. The differentiation of anaemia in rheumatoid arthritis: parameters of iron-deficiency in an Indian rheumatoid arthritis population / С. Nikolaisen, Y. Figenschau, J.C. Nossent // Rheumatol Int. – 2008. – № 6. – Р.507–511.
6. Ravindran V. Anemia in rheumatoid arthritis: high prevalence of iron-deficiency anemia in Indian pa-tients / V. Ravindran, S. Jain, D.S. Mathur // Rheumatol Int. – 2006. – № 12. – Р.1091–1095.
7. Agrawal S. Anaemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness / S. Agrawal, R. Misra, A. Aggrawal // Ann Rheum Dis. – 1990. – № 2. – Р. 93–98.
8. Vreugdenhil G. Anaemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness / G. Vreugdenhil, A.W. Wognum, H.G. van Eijk, A.J. Swaak // Ann Rheum Dis. – 1990. – № 2. – Р. 93–98.
9. Kuruvilla J. Aplastic anemia following administration of a tumor necrosis factor-alpha inhibitor / J. Ku-ruvilla, H.A. Leitch, L.M. Vickars // Eur J Haematol. – 2003. – № 5. – Р. 396–398.
10. Vucelić V. Combined megaloblastic and immunohemolytic anemia associated--a case report / V. Vucelić, V. Stancić, M. Ledinsky // Acta Clin Croat. – 2008. – № 4. – Р.239–243.
11. Соломатина М.А. Анемия при хронических заболеваниях / М.А. Соломатина, В.К. Альпидовский // Вестник Российского университета дружбы народов. – 1999. – № 1. – С. 36–38.
12. Raj D.S. Role of Interleukin-6 in the Anemia of Chronic Disease / D.S Raj // Semin Arthritis Rheum. – 2009. – № 5. – Р. 382–388.
13. Matsumura I. Pathogenesis of anemia of chronic disease / I. Matsumura, Y. Kanakura // Nippon Rinsho. – 2008. – № 3. – Р. 535–539.
14. Weiss G. Pathogenesis and treatment of anaemia of chronic disease / G. Weiss // Blood Rev. – 2002. – № 2. – Р. 87–96.
15. Maciejewski J.Р. Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha // J.Р Maciejewski, С. Selleri, T. Sato // J. Clin Invest. – 1995. – №96. – Р. 1085–1092.
16. Rafferty S.P. Inhibition of hemoglobin expression by heterologous production of nitric oxide synthase in the K562 erythroleukemic cell line / S.P. Rafferty, J.B. Domachowske, H.L. Malech // Blood. – 1996. – № 88. – Р. 1070–1078.
17. Li H. Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS / Н. Li, M.J. Rose, L. Tran, J. Zhang, L.P. Miranda, С.А. James, B.J. Sasu // J. Pharmacol Toxicol Methods. – 2009. – № 179. – Р. 171–180.
18. Raj D.S. Role of Interleukin-6 in the Anemia of Chronic Disease / D.S Raj // Semin Arthritis Rheum. – 2009. – № 5. – Р. 382–388.
19. Pigeon C. A new mouse liver specific protein homologous to human antibacterial peptid hepcidin is overexpressed during iron overload / С. Pigeon, G. Ilyin, В. Courselaud // J. Biol. Chem. – 2001. – № 276. – Р. 7811–7819.
20. Kemna E. Time_course analisis of hepcidin, serum iron and plasma cytokine levels in humans injected with LPS / Е. Kemna, Р. Pickkers, Е. Nemeth // Blood. – 2005. – № 5. – Р. 1864–1866.
21. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin / M.D. Knutson, М. Oukka, L.M. Koss [et al.] // Proc Natl Acad Sci U S A. – 2005. – № 102. – Р. 1324-1328.
22. Evidence for differential effects of hepcidin in macrophages and intestinal epithelial cells. Gut. 2008 Mar; 57(3):374-82. Chaston T. Evidence for differential effects of hepcidin in macrophages and in-testinal epithelial cells / Т. Chaston, В. Chung, М. Mascarenhas [et al.] // Gut. – 2008. – № 57. – Р. 374–382.
23. Lang F. Mechanisms and significance of eryptosis / F. Lang, K.S. Lang, Р.А. Lang // Antioxid Redox Signal. – 2006. – № 8. – Р. 1183–1192.
24. Moldawer L.L. Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo / L.L. Moldawer, М.А. Marano, Н. Wei // FASEB J. – 1989. – № 3. – Р. 1637–1643.
25. Weiss G. Anemia of Chronic Disease / G. Weiss, L.T Goodnough // New. Eng. J. Med. – 2005. – № 10. – Р. 1011–1023.
26. Вуд Мари Э. Секреты гематологии и онкологии / Мари Э.Вуд, Пол А.Банн [пер. с англ.].- Москва : Бином, 1997. –38 c.
27. Baer A.N. The pathogenesis of anemia in rheumatoid arthritis: a clinical and laboratory analysis / A.N. Baer, E.N. Dessypris, S.B. Krantz // Semin Arthritis Rheum. – 1990. – № 4. – Р. 209–223.
28. Smith M.A. Anaemia of chronic disease in rheumatoid arthritis: effect of the blunted response to erythro-poietin and of interleukin 1 production by marrow macrophages // М.А. Smith, S.M. Knight, P.J. Maddi-son // Ann Rheum Dis. – 1992. – № 6. – Р. 753–757.
29. Kullich W. Effects of the chemokine MIP-1alpha on anemia and inflammation in rheumatoid arthritis / W. Kullich, F. Niksic, K. Burmucic // Z Rheumatol. – 2002. – № 61. – Р. 568–576.
30. Zhu Y. The correlation of cytokines TNF alpha, IFN-gamma, Epo with anemia in rheumatoid arthritis / Y. Zhu, D. Ye, Z. Huang // Zhonghua Xue Ye Xue Za Zhi. – 2000. – № 21. – Р. 587–590.
31. Means R.T. Recent developments in the anemia of chronic disease / R.T. Means // Curr. Hematol. Rep. – 2003. – № 2. – Р. 116–121.
32. Papadaki H.A. Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy / Н.А. Papadaki, H.D. Kritikos, V. Valatas // Blood. – 2002. – № 100. – Р. 474–482.
33. Glossop J.R. Anemia in rheumatoid arthritis: association with polymorphism in the tumor necrosis factor receptor I and II genes / J.R. Glossop, P.T. Dawes, A.B. Hassell // J Rheumatol. – 2005. – № 9. – Р. 1673–1678.
34. Segal R., Baumoehl Y., Elkayam O. (2004) Anemia, serum vitamin B12, and folic acid in patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus. Rheumatol Int, 24(1): 14–19.
35. Nakazaki S. Cytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis / S. Nakazaki, Т. Murayama // Ryumachi. – 2001. – № 6. – Р. 929–937.
36. Bolla G. Concurrent acute megaloblastic anaemia and pneumonitis: a severe side-effect of low-dose methotrexate therapy during rheumatoid arthritis / G. Bolla, Р. Disdier, J.R. Harle // Clin Rheumatol. – 1993. – № 4. – Р. 535–537.
37. Lim A.Y. Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years / A.Y. Lim, K.Gaffney, D.G. Scott // Rheumatology – 1995. – № 8. – Р. 1051–1055.
38. Hirshberg B. Safety of low dose methotrexate in elderly patients with rheumatoid arthritis / В. Hirshberg, M.Muszkat, O.Schlesinger // Postgrad Med J. – 2000. – № 902. – Р. 787–789.
39. Nurmohamed М.Т. Cyclosporin for sulphasalazine-induced aplastic anaemia in a patient with early rheumatoid arthritis / М.Т. Nurmohamed, М.Soesan, М.Н. van Oers // Rheumatology. – 2000. – № 12. – Р. 1431–1433.
40. Yan A. Gold induced marrow suppression: a review of 10 cases / А. Yan, P. Davis // J Rheumatol. – 1990. – № 1. – Р. 47–51.
41. Azathioprine-induced suicidal erythrocyte death / С. Geiger, M. Föller, K.R. Herrlinger [et al.] // Inflamm Bowel Dis. – 2008. – № 8. – Р. – 1027–1032.
42. Effects of chloroquine treatment on circulating erythropoietin and inflammatory cytokines in acute Plas-modium falciparum malaria / А. Ballal, A. Saeed, P. Rouina [et al.] // Ann Hematol. – 2009. – № 5. – Р. 411–415.
43. Giordano N. Increased storage of iron and anaemia in rheumatoid arthritis: usefulness of desferriox-amine / N. Giordano, A. Fioravanti, S. Sancasciani // Br Med J. – 1984. – № 6450. – Р. 961–962.
44. Red cell ferritin content: a re-evaluation of indices for iron deficiency in the anaemia of rheumatoid ar-thritis / А. Davidson, М.В. Van der Weyden [et al.] // Br Med J. – 1984. – № 289. – Р. 648–650.
45. Saravana S. Anemia of chronic disease in patients with rheumatoid arthritis--use of zinc protoporphyrin (ZPP) levels / S. Saravana, A. Rai // J Rheumatol. 1990. – № 2. – Р. 446.
46. Garrett S. Zinc protoporphyrin and iron-deficient erythropoiesis / S. Garrett, M. Worwood // Acta Hae-matol. – 2004. – № 91. – Р. 21–25.
47. Hastka J. Zinc protoporphyrin in anemia of chronic disorders / J. Hastka, J.J.Lasserre, A. Schwarzbeck // Blood. – 1993. – № 81. – Р. 1200–1204.
48. Margetic S. Soluble transferrin receptor and transferrin receptor-ferritin index in iron deficiency anemia and anemia in rheumatoid arthritis / S. Margetic, E. Topic, D.F Ruzic // Clin Chem Lab Med. – 2005. – № 3. – Р. 326–331.
49. Chijiwa Т. Serum transferrin receptor levels in patients with rheumatoid arthritis are correlated with indi-cators for anaemia / Т. Chijiwa, К.Nishiya, К.Hashimoto // Clin Rheumatol. – 2001. – № 5. – Р. 307–313.
50. Doyle M.К. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials / М.К. Doyle, M.U. Rahman, C. Han // Semin Arthritis Rheum. – 2009. – № 2. – Р.123–131. Epub 2008.
51. Dufour C. Etanercept as a salvage treatment for refractory aplastic anemia / С. Dufour, R. Giacchino, P. Ghezzi // Pediatr Blood Cancer. – 2009. – № 4. – Р. 522–525.
52. Ortiz Z. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheu-matoid arthritis / Z. Ortiz, В. Shea, М. Suarez Almazor // Cochrane Database Syst Rev. – 2008. – № 2.
53. Harten Р. Reducing toxicity of methotrexate with folic acid / Р. Harten // Z Rheumatol. – 2005. – № 5. – Р. 353–358.
54. Morgan S.L. Methotrexate in rheumatoid arthritis: folate supplementation should always be given / S.L. Morgan, J.E. Baggott, G.S. Alarcón // BioDrugs. – 1997. – № 3. – Р. 164–175.
55. NKF-K/DOQI Clinical Practice Guidelines for anemia of chronic kidney disease: update 2000 // Am. J. Kidney Dis. — 2001. – № 37. – Р. 182–238.
56. Ruiz-Argüelles G.J. Ineffectiveness of oral iron hydroxide polymaltose in iron-deficiency anemia / G.J. Ruiz-Argüelles, А. Díaz-Hernández, С. Manzano // Hematology. – 2007. – № 12. – Р. 255–256.
57. Reynoso-Gómez Е. Safety and efficacy of total dose intravenous iron infusion in the treatment of iron-deficiency anemia in adult non-pregnant patients / Е. Reynoso-Gómez, V. Salinas-Rojas, А. Lazo- Langner // Rev Invest Clin. – 2002. – № 54. – Р. 12–20.
58. Weiss G., Goodnough L.T. Anemia of Chronic Disease / G. Weiss, L.T. Goodnough // New. Eng. J. Med. -2005. – № 10. – Р. 1011–1023.
59. Vidal-Alaball J. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency / J. Vi-dal-Alaball, С.С. Butler, К. Hood // Cochrane Database Syst Rev. – 2005. – № 3.
60. Bolaman Z. Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study / Z. Bolaman, G. Kadikoylu, V. Yukselen // Clin Ther. – 2003. – № 12. – Р. 3124–3134.
61. Dyjas R. Influence of recombinant human erythropoietin (rHuEPO) on plasma levels of selected hor-mones in females with rheumatoid arthritis / R. Dyjas, M. Bułanowski, R. Ficek // Pol Arch Med Wewn. – 2005. – № 114. – Р. 731–737.
62. Arndt U. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin / U. Arndt, J.P. Kaltwasser, R. Gottschalk // Ann Hematol. – 2005. – № 3. – Р. 159–166.
63. Pettersson Т. Effect of exogenous erythropoietin on haem synthesis in anaemic patients with rheumatoid arthritis / Т. Pettersson, К. Rosenlöf, Е. Laitinen // Br J Rheumatol. – 2004. – № 6. – Р. 526–529.
64. Gudbjörnsson B. Response of anaemia in rheumatoid arthritis to treatment with subcutaneous recombi-nant human erythropoietin / В. Gudbjörnsson, R. Hällgren, L. Wide // Ann Rheum Dis. – 1992. – № 6. – Р. 747–752.
65. Peeters H.R. Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset / H.R. Peeters, M. Jongen-Lavrencic // Ann Rheum Dis. – 1996. – № 55. – Р. 162–168
66. Bhattacharya N. Placental umbilical cord whole blood transfusion to combat anemia in the background of advanced rheumatoid arthritis and emaciation and its potential role as immunoadjuvant therapy / N. Bhattacharya // Clin Exp Obstet Gynecol. – 2006. – № 33. – Р. 28–33.
67. Burt R.K. Future strategies in hematopoietic stem cell transplantation for rheumatoid arthritis / R.K. Burt, W. Barr, Y. Oyama // J Rheumatol Suppl. – 2001. – № 64. – Р. 42–48.
68. Lowenthal R.M. Twenty-year remission of rheumatoid arthritis in 2 patients after allogeneic bone mar-row transplant / R.M. Lowenthal, D.S. Gill // J Rheumatol. – 2006. – № 33. – Р. 812–813.
Як цитувати
Vatutin, M., Kalinkina, N., & Smyrnova, G. (1). ANEMIA AND RHEUMATOID ARTHRITIS. Вісник Харківського національного університету імені В. Н. Каразіна. Серія «Медицина», (19), 76-82. вилучено із https://periodicals.karazin.ua/medicine/article/view/6943
Номер
Розділ
Reviews
Вісник Харківського національного університету імені В. Н. Каразіна, серія Медицина має такі умови авторського права:
1. Автори зберігають авторські права та надають журналу право на першу публікацію разом із роботою, яка одночасно ліцензується згідно з ліцензією Creative Commons Attribution License, яка дозволяє іншим ділитися роботою з визнанням авторства роботи та першої публікації в цьому журналі.
2. Автори можуть укладати окремі додаткові договірні угоди щодо неексклюзивного розповсюдження опублікованої журналом версії роботи з підтвердженням її початкової публікації в цьому журналі.
3. Авторам дозволяється та заохочується публікувати свої роботи в Інтернеті до та під час процесу подання, оскільки це може призвести до продуктивного обміну, а також до раннього та більшого цитування опублікованої роботи.
